In this study, the abilities of constitutive and conditional forms of the three Raf kinases to abrogate the cytokine dependency of FDC-P1 cells were examined. The constitutively active forms (⌬) of all three Raf kinases were fused to the hormone-binding domain of the estrogen receptor (ER), rendering their activities conditionally dependent upon exogenous ␤-estradiol. The vast majority of ⌬Raf:ER-infected FDC-P1 cells remained cytokinedependent; however, cells were obtained at low frequency in which expression of ⌬Raf:ER abrogated cytokine dependency. Isoform specific differences between the Raf kinases were observed as cytokine-independent cells were obtained more frequently from ⌬A-Raf:ER than either ⌬Raf-1:ER or ⌬B-Raf:ER infected cells. To determine whether the regulatory phosphorylation sites in the Raf proteins were necessary for abrogation of cytokine dependency, they were changed by site-directed mutagenesis. Substitution with phenylalanine eliminated the transforming ability of the ⌬B-Raf:ER and ⌬Raf-1:ER kinases. 
Introduction
The proliferation of many hematopoietic precursor cells is promoted by interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor (GM-CSF), stem cell factor (SCF), flt-3 ligand (the ligand for the tyrosine kinase receptors flt-2 and flt-3) as well as other growth factors. [1] [2] [3] [4] [5] [6] [7] Hematopoietic cell lines have been isolated which require IL-3 or in some cases GM-CSF for proliferation. [8] [9] [10] These cytokines are in some cases referred to as survival factors since they can act to inhibit apoptosis. FDC-P1 is an IL-3/GM-CSF-dependent cell line derived from the bone marrow of normal DBA/2 mice and is representative of early hematopoietic precursor cells. 8 FDC-P1 cells proliferate continuously in culture as long as either IL-3 or GM-CSF is provided, but they are non-tumorigenic upon injection into syngeneic mice. 6, 8, [10] [11] [12] The loss of cytokine dependency by hematopoietic cells may be an important factor in the development of leukemias. Spontaneous factor-independent cells are rarely (Ͻ10 −7 ) recovered from the FDC-P1 line which makes it an attractive model system to analyze the effects various oncogenes have on signal transduction and leukemogenesis. 6, 8, [10] [11] [12] IL-3 and GM-CSF exert their biological activity by binding to the IL-3 and GM-CSF receptors, respectively. 1, [5] [6] [7] These receptors are comprised of a ligand-specific ␣-subunit, and a common ␤-subunit (␤ c ), which is essential for signal transduction. 1, 13 The binding of these cytokines to their cognate receptors activates a Janus (Jak2) protein tyrosine kinase, which leads to the phosphorylation and dimerization of signal transducers and activators of transcription (Stats). In turn, the Stats regulate the expression of key genes involved in cell growth. 1, 14, 15 Activation of Jak2 by IL-3 may occur by receptor aggregation resulting in the multimerization of associated Jak2 proteins. In addition to Jak activation, receptor ligation promotes phosphorylation of the Shc protein. Shc then recruits the Grb2/Sos complex to the ␤ c chain resulting in stimulation of Ras. Ras promotes the sequential activation of Raf, MEK and MAP (ERK1 and ERK2) kinases. 1, [16] [17] [18] [19] [20] The ERK proteins can induce the activation of the Elk-1 transcription factor and p90 Rsk . p90
Rsk can sequentially activate the CREB and Egr transcription factors that bind specific promoter regions to induce gene transcription. [21] [22] [23] [24] [25] [26] [27] Recently, it has also been shown that ERK2 can phosphorylate Bcl-2 and this results in an anti-apoptotic response. 14, 18, 20 Evidence suggests that this pathway is intimately associated with the control of the apoptotic machinery in myelo-monocytic cells. 1, 7, 20 The raf gene is evolutionarily conserved as raf genes have been described in Drosophila and C. elegans. 28 There are three related raf genes in the mammals: A-raf, B-raf and raf-1. 15, 28, 29 These genes code for the respective Raf proteins that serve as a family of serine-threonine kinases. Loss of Raf expression can have severe developmental consequences for the organism. [30] [31] [32] [33] Each Raf gene is expressed in hematopoietic cells, although the level of expression differs. 1, 15 The Raf proteins have been dissected into three different functional domains; CR1, CR2, and CR3. 1 The CR1 region has the binding site for an activated Ras protein. 16 The CR2 region negatively regulates the Raf kinase domain (CR3) which is located in the carboxyl-terminal half of the Raf protein. 16, [33] [34] [35] [36] [37] N-terminal deleted forms of these Raf proteins result in constitutively activated oncoproteins which transform fibroblastic murine NIH-3T3 cells [33] [34] [35] and abrogate the cytokine dependency of hematopoietic cells. 15, 36, 37 Amino acids 340 and 341 of the wild-type p74
Raf-1 protein are normally both tyrosine residues. 15, 38, 39 These residues are critical for the ability of the Raf-1 protein to transform fibroblastic NIH-3T3 cells. 35 Phosphorylation of these residues results in the activation of the Raf-1 kinase. Moreover, mutation of these amino acids to aspartic acid leads to constitutive Raf activation and results in oncogenic conversion. Thus, there are at least two means to induce constitutive Raf expression, deletion of the N-terminal regulatory domain or mutation of the two tyrosine residues at a conserved position to aspartic acid. In contrast, changing these amino acids to phenylalanine results in a Raf protein which does not transform NIH-3T3 cells. 16, 35, 39 In the wild-type A-Raf protein, the analogous amino acids are tyrosines 299 and 300. Whereas, the wild-type B-Raf protein contains aspartic acid residues at the corresponding positions (492 and 493). The B-Raf kinase is 50-fold more active than Raf-1 and approximately 500-fold more active than A-Raf. 34, 35, 39, 40 It is has been postulated that the aspartic acid residues present in B-Raf confer a very strong serine-threonine kinase activity. 16, 34, 35 The B-Raf protein phosphorylates the MAP kinase kinase (MEK1) more efficiently than either the Raf-1 or A-Raf proteins. 34, 35, 40 v-Ha-Ras can in some cases efficiently relieve the cytokine dependency of hematopoietic cells. [10] [11] [12] 41 However, the efficiency of hematopoietic cell transformation by activated and viral Raf was much lower than that observed with v-HaRas and other oncoproteins. 12, 14, 37, 42, 43 Some studies have shown that v-Raf overexpression will not abrogate the growth factor-dependency of certain IL3-dependent cell lines. 43 However, enforced v-Raf expression can suppress apoptosis temporarily (1 to 2 days) in these cells. We are interested in the transforming capacity of Raf because it is located at a pivotal position in signal transduction as well as apoptotic pathways.
Abrogation of cytokine dependency requires the prevention of apoptosis. In addition to promoting proliferation, cytokines affect the apoptotic machinery that controls cell survival. Activated Raf has been shown to participate in the suppression of apoptosis upon activation by growth factor ligation. 7 Apoptosis is strongly influenced by the activity of Bcl-2 and its family members. 1, [44] [45] [46] [47] [48] Both Bcl-2 and Bcl-x L promote cell survival, whereas Bax and Bad promote cell death. The precise details of how cytokines influence the function of these proteins are not fully defined. Recent evidence has suggested that protein subcellular localization and phosphorylation leading to the control of protein-protein interactions may be central to the process. 14, 20 Moreover, certain members of the Ras signaling pathway (Raf, ERK) have been shown to physically interact with and phosphorylate the Bcl-2 protein. 1, 14, 20 
Materials and methods

Cell lines and growth factors
Cells were maintained in a humidified 5% CO 2 incubator with Dulbecco's modified Eagle's medium (DMEM; Life Technologies, Gaithersburg, MD, USA) complemented with 5% ironsupplemented bovine calf serum (BCS) (Hyclone, Logan, UT, USA). The IL-3/GM-CSF dependent murine myeloid cell line FDC-P1 8 was cultured in medium supplemented with 20% WEHI-3B (D − ) conditioned medium (WCM) as a source of ILLeukemia 3. Estradiol-dependent FD/⌬Raf:ER cells were grown in DMEM + 5% BCS + 1 M ␤-estradiol (Sigma, St Louis, MO, USA). Cytokine-independent (FD/⌬Raf-1(DMEM), FD/Raf-1(DMEM)) and autocrine-transformed ((FD/GM   +   -3, produces  GM-CSF), (FD/IL3 + -1, produces IL-3) and (WEHI-3B, produces IL-3)) were cultured in DMEM + BCS in the absence of exogenous cytokines. The MEK1 inhibitor, PD98059, was purchased from New England Biolabs (Beverly, MA, USA) and dissolved in dimethysulfoxide (DMSO; Fisher, Raleigh, NC, USA) and used at a concentration of 10 to 50 M. The phorbol ester, phorbol 12-myristate 13-acetate (PMA) (Sigma) was also dissolved in DMSO and used at a concentration of 10 to 50 nM.
Assays of 3 H-thymidine incorporation
Log phase cultures of cells were incubated for 24 h in the presence or absence of either IL-3 or ␤-estradiol as indicated. Cellular proliferation assays were performed with 3 H-thymidine (6.7 Ci/mmol; NEN, Boston, MA, USA) as described [10] [11] [12] 15, 46 which was added during the last 4-6 h of incubation.
Retroviral infection of cells
The following puromycin-resistant (puro r ) retroviruses were used in this study: (1) pBP3⌬Raf-1 [YY] :ER which contains the catalytic domain of human Raf-1 (aa 305-648) fused to hormone binding region of the human estrogen-receptor (hbER) segment and inserted into the pBabePuro3 retroviral vector. 35, 49 These activated Raf constructs lack the CR1 and CR2 domains. (2 and 3) pBP3⌬Raf-1 [DD] :ER and pBP3⌬Raf-1 [FF] :ER in which the wild-type tyrosine [YY] amino acids of Raf-1 at positions 340 and 341 were replaced by aspartic acid [DD] or phenylalanine [FF] by site-directed mutagenesis, respectively. 35 (4) pBP3⌬A-Raf [YY] :ER which encodes the catalytic domain of murine A-Raf fused to the hbER and inserted into pBP3. 35 (5 and 6) pBP3⌬A-Raf [DD] :ER and pBP3⌬A-Raf [FF] :ER in which the wild-type [YY] amino acids of A-Raf at positions 299 and 300 were replaced by [DD] or [FF] , respectively. 35 (7) pBP3⌬B-Raf [DD] :ER which encodes the catalytic domain of murine B-Raf fused to the hbER and inserted into pBP3. 41 (8 and 9) pBP3⌬B-Raf [FF] :ER and pBP3⌬B-Raf [YY] :ER in which the wild-type [DD] amino acids of B-Raf at positions 492 and 493 were replaced by [FF] or [YY], respectively; and (10) pBP3⌬Raf-1301:ER kinase-inactive, which contains the lysine → typtophan substitution at the ATP binding site of the catalytic domain of Raf-1. 35, 50 Puro r FDC-P1 cells were isolated by selection in 500 ng/ml puromycin (Sigma) in the presence of IL-3.
The following G418-resistant (neo r ) retroviruses were used in this study: (1) pLNCRaf-1 which encodes the full length human raf-1 cDNA inserted into the pLNCX retroviral vector; 33 (2) pLNC⌬raf-1 which contains the same ⌬raf-1 cDNA as described above inserted into the pLNCX retroviral vector; 33 (3) fpGV-100 which encodes v-Src, isolated from the Schmiddt-Ruppin (A) strain of Rous sarcoma virus, inserted into the fpGV-1 retroviral vector 51 and (4) pLSv-Ha-Ras which encodes v-Ha-ras inserted into the pLS retroviral vector. 52 As a control, FDC-P1 cells were also infected with the pLNL6 empty retroviral vector, which contains neo r . 53 neo r FDC-P1 cells were isolated by selection in medium containing G418 (2 mg/ml, Life Technologies).
Plasmid DNAs containing recombinant retroviruses were transfected into the retroviral packaging cell lines 2 or PA317 with lipofectin (Life Technologies) and retroviruses were passed sequentially from one cell line to the other to amplify their titers as described. [10] [11] [12] 15, 36 FDC-P1 cells were infected with viral stocks as described. [10] [11] [12] 15, 26 
Preparation of cell extracts and analysis by Western blotting
Cells were washed twice with cold phosphate-buffered saline (PBS) and lysed on ice in gold lysis buffer (GLB) containing 20 mM Tris (pH 7.6), 137 mM NaCl, 5 mM Na 2 EDTA, 10% (vol/vol) Triton X-100, 1 mM phenylmethylsulfonyl fluoride, 1 mM aprotinin, 1 mM leupeptin, 1 M pestatin A, 1 mM sodium orthovanadate, 1 mM ethylene glycol-bis (␤-aminoethyl ether)-N,N,N′,N′tetraactic acid (EGTA), 10 mM sodium fluoride, 1 mM tetrasodium PP i , and 100 M ␤-glycerophosphate. Insoluble material was removed by centrifugation at 12 000 g as described. 15, [32] [33] [34] [35] [36] All chemicals were purchased from Sigma unless otherwise indicated. The protein concentration of the soluble material was estimated as described previously. 15, [32] [33] [34] [35] [36] Cellular proteins were analyzed by electrophoresis through polyacrylamide gels followed by Western immunoblotting on to polyvinlidene difluoride membranes (PVDF, Immunobilon P; Millipore, New Bedford, MA, USA). Western blots were incubated with the appropriate primary Ab at a dilution of 1:1000 to 1:2000 and then washed in Tris-buffered saline containing 0.05% (vol/vol) Nonidet P-40. Antigen-antibody complexes were visualized by using 1:10 000-diluted goat ␣-rabbit antiserum, sheep ␣-mouse antiserum, or protein A coupled to horseradish peroxidase and the enhanced chemiluminescence detection system (Amersham) as described. 15, [32] [33] [34] [35] [36] The blots were exposed to Kodak XAR5 X-ray film (Rochester, NY, USA). Western blots were 'stripped' for reprobing with other primary Abs by incubation for 2 h at 68°C in a buffer containing 0.2 M glycine (pH 2.5), and 1% (wt/vol) sodium dodecyl sulfate (SDS).
Determination of Raf kinase activity
Cells to be examined for kinase activity were grown in phenol red free DMEM (Life Technologies) which contained charcoalstripped BCS. Cells were lysed as above and 100 g of cellular protein was incubated for 12 to 24 h at 4°C with 2 l of an ␣-ER polyclonal antiserum (HC20; Santa Cruz Biotechnology, Santa Cruz, CA, USA) and 50 l of a 50% (v/v) slurry containing protein A conjugated to sepharose beads as described. 15, [32] [33] [34] [35] [36] Immune-complexes were collected and washed twice with GLB and once with a Raf kinase wash buffer (25 mM HEPES pH 7.4 and 10 mM MgCl 2 in GLB). Immune-complexes were incubated for 30 min at 30°C in a reaction mix containing 1 mM MnCl 2 , 1 mM DTT, 50 M ATP, 10 Ci of ␥-32 P-ATP and 50 ng of kinase-inactive GST-MEK1 as a substrate. The GST-MEK1 was a kinase-dead protein purchased from Upstate Biotechnology (UBI, Lake Placid, NY, USA). The reaction mix was brought to a final volume of 15 l with Raf kinase wash buffer. The reactions were analyzed and quantitated on SDS polyacrylamide gels as described above. The levels of the transfected ⌬Raf:ER proteins in the reaction were determined by subsequently probing the Western blots with an ␣ER polyclonal Ab.
Determination of MEK activity
Aliquots from unfractionated cell lysates containing 60 g of total protein were incubated for 30 min at 30°C in a reaction mix containing 40 mM HEPES pH 7.4, 10 mM MgCl 2 , 1 mM DTT and 40 M ATP and 2 g of bacterially expressed rp44, which is an enzymatically inactive form of the p44 MAP kinase (ERK1). The reaction mixtures were electrophoresed through a 10% polyacrylamide gel. Tyrosine phosphorylation of rp44 was quantitated by probing the Western blot with 4G10-hrp, a horseradish peroxidase-conjugated ␣-phosphotyrosine MoAb as described. [33] [34] [35] Determination of p42/p44 MAP kinase activity Cells were deprived of either IL-3 or ␤-estradiol for 24 h in phenol-red free medium that contained 5% charcoal-stripped BCS. Then the cells were pulsed with cytokine, different concentrations of ␤-estradiol or the positive control, 10 nM PMA, for varying periods of time. Cells were washed and resuspended in serum-free DMEM. One ml, containing 1.25 × 10 6 cells, was added to microfuge tubes and placed at 37°C for at least 1 h prior to the start of the treatment. Cells were stimulated or mock-stimulated by the addition of PMA, ␤-estradiol, IL-3, or DMSO to the tubes in a 10 l volume. Following stimulation for the indicated time, the tubes were centrifuged in a microcentrifuge for 30 s, the supernatants were removed, cell pellets were resuspended in 110 l of cold lysis buffer (25 mM Tris-HCl, pH 7.4; 50 mM NaCl; 0.5% sodium deoxycholate; 2% NP-40; 0.2% SDS; 1 mM phenymethylsulfonyl fluoride PMSF; 50 g/ml aprotinin, 50 M leupeptin; 0.5 mM Na 3 VO 4 ) and placed on ice for 15 min. Lysates were centrifuged for 15 min at 14 000 g in an Eppendorf microcentrifuge, supernatants (98 l) were removed and mixed with 42 l of 3.3× sample buffer (200 mM Tris-HCl, pH 6.8; 33% glycerol; 6.6% SDS; 16.6% ␤-mercaptoethanol; 0.04% bromophenol blue). Samples were boiled (5 min) and frozen. Fifteen microliters of prepared samples were electrophoresed through a 10% SDS-PAGE gel, and proteins were electrophoretically transferred to PVDF membranes. Membranes were incubated overnight at 4°C in blocking buffer (25 mM Tris-HCl, pH 8.0; 125 mM NaCl; 0.1% Tween 20; 1% BSA; 0.1% sodium azide). Membranes were then incubated for 2 h with the primary antibody diluted in blocking buffer (anti-active MAP kinase, 1:20 000 (Promega) or anti-p90
Rsk (Santa Cruz), 1:10 000). The blots were washed twice in TBST (25 mM Tris-HCl, pH 8.0; 125 mM NaCl; 0.025% Tween 20) and incubated with alkaline phosphatase (AP)-conjugated goat anti-rabbit Ig or goat-anti mouse Ig (Promega, 1:10 000 in TBST) for 1 h at room temperature. The blots were washed twice in TBST and developed with the colorogenic substrates BCIP and NBT (Promega Protoblot AP System). The data shown are representative of at least two independently performed experiments.
Polymerase chain reaction amplification of cytokine mRNA transcripts
Total cytoplasmic RNA was prepared as described 5 and 1 g was included in a 20 l cDNA synthesis reaction containing: reverse transcriptase buffer, 1 mM of each dNTP, 20 g/ml oligo-dT and 20 units MoMuLV reverse transcriptase. After incubation at 42°C for 40 min, the reaction was terminated by addition of H 2 O. For PCR amplification, 5 l cDNA were included in a 50 l reaction mixture containing PCR buffer, dNTP, 1-2 units Taq polymerase and 1 M of each oligonucleotide primer. The primers for murine IL-3 were: 5′AAT-CAGTGGCCGGGATACCC3′ and 5′CGAAATCATCCAG ATCTCG3′ defining a 200 bp cDNA fragment which could readily be distinguished from a genomic IL-3 DNA fragment by size (Ͼ1 kb). The primers for murine GM-CSF were: 5′CCTGAGGAGGATGTGGCTGC3′ and 5′CTGTCCAA GCTGAGTCAGCG3′ defining a 601 bp fragment. The primers for murine ␤ 2 -microglobulin were 5′TTCTCTCACT GACCGGCCTG3′ and 5′CAGTAGACGGTCTTGGGCTC3′ defining a 308 bp fragment. Forty cycles of PCR were performed to detect cytokine cDNAs. The PCR products were electrophoresed on 1% agarose gels and visualized after ethidium bromide staining of the gel.
Apoptosis assays using Annexin V
Cells (ෂ1 × 10 6 ) were collected and washed twice in 1 ml of PBS. The cells were then resuspended in 100 l of Annexin V-FITC solution (1 g/ml of Annexin V-FITC in binding buffer (Boehringer Mannheim, Indianapolis, IN, USA, 10 mM Hepes, pH 7.4, 140 mM NaCl, and 2.5 mM CaCl 2 )) and then incubated in the dark at room temperature for 15 min. Following the incubation, the cells were washed once in PBS as before. After removing the PBS, the cells were resuspended in 100 l of propidium iodide (PI) solution (Boehringer Mannheim; 10 g/ml in binding buffer) and incubated in the dark for 15 min at room temperature. Once the incubation was complete, 0.7 ml of binding buffer was added directly to the samples which were then analyzed using FACScan.
Isolation of low molecular weight DNA for apoptosis assays
1 × 10 7 cells (4 × 10 5 /ml) were grown in the different conditions for 1 day. The cells were pelleted by centrifugation, resuspended in 500 l of lysis buffer (20 mM Tris-HCl, pH 7.4, 10 mM EDTA, 0.2% Triton X-100) and placed on ice for 10 min. The lysate was then centrifuged for 10 min at 14 000 g, and the pellet was discarded. 10 l of 10 mg/ml protease K (Sigma) was added to the supernatant, and the mixture was incubated overnight at room temperature. The solution was phenol extracted twice followed by chloroform extraction once. The aqueous phase was saved each time. The nucleic Leukemia acids were ethanol precipitated and subsequently resuspended in H 2 O. The concentration of the nucleic acids was determined, and 40 g were treated with 10 l of 1 mg/ml RNase A for 5-10 min. The remaining DNA was electrophoresed in an agarose gel with 1× TBE (1× = 0.09 M Tris borate, 0.002 M EDTA) running buffer and visualized with ethidium bromide.
Results
Capabilities of different activated Raf proteins to abrogate the cytokine dependency of hematopoietic cells
To determine whether deregulated Raf activation could relieve cytokine dependency of hematopoietic cells, FDC-P1 cells were infected with retroviruses encoding the Raf oncoproteins as well as various controls. Two days post infection, the cells were plated in medium containing IL-3 and selective drug and stably infected pools recovered. Titration experiments indicated that each retroviral pool contained 10 4 to 10 5 different infected FDC-P1 cells.
As a control to determine that sufficient puromycin or G418 were present in the media to select for retrovirally infected cells, the capacities of mock-infected FDC-P1 cells to grow in the presence of puromycin or G418 were determined. No colonies were observed, indicating that the selection conditions were adequate to isolate retrovirally infected cells (Table 1) .
To determine the frequencies of abrogation of cytokine dependency, limiting dilution analyses were performed on the pools of stably infected cells. Briefly different concentrations Determined by limiting dilution analysis followed by Poisson statistical analysis.
Leukemia of cells/well were plated (0.1 to 10 5 cells/well) in either IL-3 or ␤-estradiol and the number of cells required to obtain 37% of the wells negative for growth (63% positive for growth) were determined by Poisson statistical analysis. For example, when uninfected parental FDC-P1 cells were plated in the presence of IL-3, a cloning efficiency of approximately 1 was observed indicating that essentially each cell could give rise to a colony. However, when the same cells were plated in medium lacking IL-3, no cytokine-independent cells were recovered (Table 1) . Since 10 7 cells/96-well plate were present in the highest cell concentration (10 5 /well), this indicates that Ͻ1 in 10 7 uninfected FDC-P1 cells grew in the absence of IL-3. As controls, the capacities of the empty retroviral vectors (pBP3puro or pLNL6) to abrogate the cytokine dependency of FDC-P1 cells were examined. No cytokineindependent cells were obtained when the puro r or neo r pools were plated in the absence of exogenous IL-3. The ability of the kinase-inactive mutant, ⌬Raf-1[301]:ER, to abrogate the cytokine dependency of FDC-P1 cells was also examined. No cytokine-independent cells were recovered after infection with this kinase-inactive mutant (Table 1) .
However, factor-independent cells were, though from the pools of cells, infected with the functionally activated ⌬Raf:ER retroviruses as 1 in 10 4 to 1 in 5 × 10 5 ⌬Raf:ER-infected cells would form a colony. Factor-independent cells were recovered more frequently from ⌬A-Raf [YY] :ER than from either ⌬Raf-1 [YY] :ER or ⌬B-Raf [DD] :ER infected cells (2.5-to 50-fold, respectively). However, only a minority of ⌬Raf:ER-infected cells grew in response to Raf activation.
To further understand the mechanism, by which the activated Raf oncoproteins could relieve the cytokine dependency of FDC-P1 cells, the effects of mutations at the regulatory phosphorylation sites were examined. These mutants were constructed by site directed mutagenesis of the tyrosine or aspartic acid residues normally contained at the regulatory phosphorylation residues of the Raf proteins. 35 Change of the tyrosine amino acids (YY 299 and 300) present in A-Raf to aspartic acid resulted in a kinase with enhanced activity 35 and increased the recovery of cytokine-independent FDC-P1 cells five-fold. In contrast, substitution of the tyrosine amino acids present in ⌬A-Raf:ER to phenylalanine reduced (five-fold), but did not eliminate the recovery of estradiol-responsive cells (Table 1 ). This result indicated that the activated A-Raf protein retained some transforming activity in hematopoietic cells even when the regulatory amino acids present in A-Raf were mutated to phenylalanine. Thus, the transforming activity of the A-Raf protein could be altered either positively (YY → DD) or negatively (YY → FF) by mutating the regulatory phosphorylation residues (Table 1) .
The effects of similar mutations on the transforming capacity of the ⌬B-Raf protein were also examined (Table 1) . While substitution of the aspartic acid residues with phenylalanine eliminated the recovery of Raf-responsive FDC-P1 cells, substitution to tyrosine did not significantly change the frequency of recovery of factor-independent cells (Table 1) . These results indicated that the ability of the B-Raf kinase to abrogate the cytokine dependency of FDC-P1 was maintained when the aspartic acid residues in the phosphorylation domain were mutated to tyrosine but not when they were changed to phenylalanine.
Finally, the effects of changing the tyrosine amino acids in the ⌬Raf-1 protein were determined. Change of these residues to phenylalanine eliminated the recovery of estradiol-responsive cells (Table 1) . Substitution with aspartic acid residues increased the recovery of cytokine-independent cells 2.5-fold. This increase is significant and was observed four times after different infections of FDC-P1 cells with different preparations of the ⌬Raf-1 [DD] :ER and ⌬Raf-1 [YY] :ER retroviruses. These results indicated that the ⌬Raf-1 or ⌬B-Raf proteins needed either tyrosine or aspartic acid residues to be present at these critical phosphorylation sites to abrogate the cytokine dependency of FDC-P1 cells. In contrast, the ⌬A-Raf:ER protein could abrogate cytokine dependency when these critical phosphorylation sites were lost by replacing them with phenylalanine.
FDC-P1 cells were also infected with the pLNCX retroviral vector containing either the full length (Raf-1) or 5′ truncated Raf-1 (⌬Raf-1) cDNAs. Cytokine-independent cells were recovered very infrequently after infection with the full-length wild-type Raf-1 oncoprotein ( Table 1 
Growth properties of ⌬Raf:ER-infected FDC-P1 cells
To examine how the expression of the ⌬Raf:ER protein altered the proliferation of the FDC-P1 cells, the growth of these cells was measured in medium containing IL-3, ␤-estradiol or no growth factor (Figure 1) . The parental FDC-P1 cell line grew only when IL-3 was present (a). The pool of ⌬Raf-1 [YY] :ER cells which had been isolated in IL-3 and puromycin containing medium displayed similar growth characteristics, as it required IL-3 for growth. These cells did not proliferate when only ␤-estradiol was added as a growth supplement (b).
Similarly, a clone that was obtained after selection of the ⌬Raf-1 [YY] :ER-infected pool in IL-3 [FD/⌬Raf-1 [YY] :ER(IL3)c1] proliferated in medium containing IL-3 but not in medium which contained ␤-estradiol (c). Whereas a clone that was obtained after selection of the ⌬Raf-1 [YY] :ER-infected pool in ␤-estradiol [FD/⌬Raf-1 [YY] :ER(Est)c1] was able to proliferate in response to ⌬Raf-1:ER activation (by the addition of ␤-estradiol), as well as when IL-3 was added (d). Importantly, the growth of these FD/⌬Raf-1 [YY] :ER(Est)c1 cells was still conditional as they required either ␤-estradiol or IL-3 to proliferate and they did not grow in the absence of these factors. Thus, the cells are conditionally transformed to grow in response to Raf.
The growth of the ⌬A-Raf [FF] :ER-infected FDC-P1 cells was also examined. The IL-3-selected clone [FD/⌬A-Raf [FF] :ER(IL3)c1] was dependent upon the addition of IL-3 and did not proliferate in the presence of ␤-estradiol alone (e). In contrast, the Raf-responsive FD/⌬A-Raf [FF] :ER clone (FD/⌬A-Raf [FF] :ER(Est)c1) was able to proliferate when either ␤-estradiol or IL-3 was added (f). This was important to determine as these cells contained the mutant ⌬A-Raf [FF] :ER protein, and it was conceivable that they proliferated by a mechanism independent of Raf activation. A lag in the proliferation of the FD/⌬A-Raf [FF] :ER(Est)c1 cells in response to ␤-estradiol was observed. This lag in proliferation was often observed with the Raf-responsive cells. Similar growth characteristics were observed with four other Raf-responsive FD/⌬A-Raf [FF] :ER clones (data not presented).
The growth properties of two clones from ⌬A-Raf [YY] :ERinfected FDC-P1 cells were also examined, one which was isolated in the presence of IL-3 (panel g, FD/⌬A-Raf [YY] :ER(IL3)c1) and one that was isolated in ␤-estradiol (panel h, FD/⌬A-Raf [YY] :ER(Est)c1). Again the IL-3-selected clone only grew when IL-3 was present (g), whereas the estradiol-selected clone proliferated when either IL-3 or ␤-estradiol was added (h).
A similar scenario was observed with the ⌬B-Raf:ER- : ER(Est)c1] proliferated in the presence of IL-3 or ␤-estradiol (j and l). In summary, the growth of the Raf-responsive cells ⌬Raf:ER-infected FDC-P1 cells was conditional, as they required either IL-3 or ␤-estradiol to proliferate. This is a stable growth characteristic as the cells have been cultured in ␤-estradiol for over 12 months, and they remain estradiol/IL-3 dependent.
Dose-dependent activation of Raf and MEK activities in ⌬Raf:ER-infected cells
To determine whether there was a dose-dependent activation of the Raf kinases in the ⌬Raf-1 [YY] :ER-infected cells, the cells were starved of ␤-estradiol and then treated with different concentrations of ␤-estradiol for . h. Raf and MEK activities were detected when the cells were treated with ␤-estradiol in concentrations ranging from 20 to 1000 nM (Figure 2a) . The Leukemia effects of these different doses of ␤-estradiol were also examined on the H-thymidine incorporation were observed between 20 and 1000 nM ␤-estradiol which correlated with the detected kinase activities. In contrast, very little 3 H-thymidine incorporation was observed in the cells which received 2 nM ␤-estradiol. No Raf kinase activity was detected in these conditions. The cells showed a low response to IL-3 after a 1-day exposure. This may have resulted from culturing the cells for Ͼ1 month in medium containing ␤-estradiol before performing these assays. The levels of the ⌬Raf:ER protein often increases after ␤-estradiol treatment, this has been shown to be due to protein stabilization induced by ␤-estradiol. [39] [40] [41] Thus there was a dose-dependent activation of Raf and MEK activities in these cells which correlated with 
Raf induces MAP kinase activation in ⌬Raf:ERtransformed cells
To determine whether the ⌬Raf:ER oncoproteins induced ERK1 and ERK2 activation in Raf-responsive FDC-P1 cells, the cells were deprived of ␤-estradiol for 24 h and then pulsed with IL-3 or different concentrations of ␤-estradiol for varying time periods (Figure 3 ). Extracts were isolated and then the blots were probed with an antibody which recognizes the activated forms of ERK1 and ERK2. Activated ERK1 and ERK2 were detected after treatment with 100 nM ␤-estradiol (top panel). ␤-estradiol and IL-3 induced the activation of ERK1 and ERK2 in ⌬Raf-1 [YY] :ER, ⌬A-Raf [YY] :ER and ⌬B-Raf [DD] :ER infected cells after treatment for 15 min (Figure 3 , bottom panels and data not shown). As controls, the effects of ethanol, DMSO and PMA on ERK1 and ERK2 activation were also examined on these cells. Ethanol and DMSO did not induce the activation of ERK1 or ERK2, whereas activated forms of these proteins were readily detected after PMA treatment in these cells. 
Importance of MEK1 in the Raf-responsive growth of FD/⌬Raf:ER cells
To determine the importance of the MEK signaling pathway on the proliferation of cells, they were treated with the MEK1 inhibitor, PD98059. This compound specifically binds the MEK1 protein and inhibits its activation. 54 To examine the specificity of growth suppression by this MEK1 inhibitor, the effects of this drug on 3 H-thymidine incorporation in other factor-independent cells was examined. PD98059 suppressed 3 H-thymidine incorporation in v-HaRas-transformed cells approximately 100-fold at 40 M (e). In contrast, the MEK1 inhibitor suppressed 3 H-thymidine incorporation only 1-3-fold in FDC-P1 cells transformed by BCR-ABL at a similar concentration (f).
The effects of PD98059 on the proliferation of FD/⌬A-Raf [YY] :ER(Est)c1 (g), FD/⌬Raf-1 [YY] :ER(Est)c1 (h) and FD/BCR-ABL(DMEM)c1 (i) cells were also examined. The MEK1 inhibitor suppressed the growth of the ⌬Raf:ER-transformed cells. These cells were dead after 24 to 48 h of exposure to this drug. Thus a functional MEK1 mediated signal transduction pathway is necessary for the growth of Raf-responsive FD/⌬Raf:ER cells. In contrast, PD98059 had less of an effect on BCR-ABL-transformed cells as they continued to grow in its presence (i).
To determine whether the effects of the MEK1 inhibitor on Raf and downstream kinase activities, the levels of Raf and MEK activities and activated ERK were examined in the PD98059 and DMSO treated FD/⌬Raf-1:ER(Est)c1 cells ( Figure 5) . Treatment of the cells with 40 M PD98059 for 24 h reduced the viability of the cells 15%. There were low levels of Raf and MEK activities detected in these cells when they were deprived of ␤-estradiol for 24 h ( Figure 5 , (−) samples). The levels of Raf activity increased five-fold when the cells were treated with IL-3 or ␤-estradiol for 1 h. Interestingly pretreatment of the cells with the MEK1 inhibitor did not significantly reduce the level of Raf activity observed after IL-3 stimulation (Figure 5a ), while it did reduce the level of Raf activity observed after ␤-estradiol stimulation. MEK activity has been previously shown to influence Raf activity. 56 Thus it is not surprising that in the cells which were growing only in response to Raf, that inhibition of MEK1 activity would effect Raf activity.
The level of MEK activity increased two-fold when the cells were treated with IL-3 for 1 h and 20-fold when the cells were treated with ␤-estradiol (b). Pre-treatment of the cells with the MEK1 inhibitor reduced the level of MEK in the IL-3 stimulated cells two-fold. In contrast, pre-treatment of the cells with the MEK1 inhibitor reduced the level of ␤-estradiol induced MEK activity 10-fold.
Pre-treatment of the cells with the MEK1 inhibitor inhibited the activation of ERK1 and ERK2 in response to ␤-estradiol (c). Interestingly activated forms of ERK1 and ERK2 were observed after IL-3 and PMA stimulation in cells that had been pretreated with PD98059. Thus IL-3 and PMA may induce alternative signal transduction pathways that result in ERK activation, which are insensitive to PD98059. This may explain in part, why the level of 3 H-incorporation observed after treatment with IL-3 and PD98059 was less affected than after treatment with ␤-estradiol and PD98059 (Figure 4) . The top por-
Figure 5
Effects of a MEK-1 inhibitor on Raf, MEK activity and ERK activation in FD/⌬RaF-1:ER(Est)C1 cells. The effects of the MEK1 inhibitor PD98059 (40 M) on Raf and MEK activity and ERK activation were determined. Cells were starved for ␤-estradiol for 24 h in the presence of either PD98059 or DMSO, the solvent for PD98059. Then cells were treated with IL-3, ␤-estradiol or PMA for the indicated time periods.
tions of these gels were probed with an antibody to p90
Rsk as a loading control for these experiments (d). The levels of p90
Rsk were relatively constant indicating that equal levels of protein were included in the lanes to detect activated ERK1 and ERK2.
Activated Raf genes induce autocrine GM-CSF expression
To determine whether the activated Raf genes induced autocrine growth factor expression, the presence of IL-3 and GM-CSF expression was determined by RT-PCR ( Figure 6 ). As controls, the presence of IL-3 and GM-CSF cDNAs was monitored in the T cell thymoma EL4 and EL4 cells stimulated with phorbol esters (a and b, lanes 1 and 2) . IL-3 and GM-CSF expression was detected in EL4 cells and the levels of cDNAs encoding IL-3 and GM-CSF increased in EL4 cells stimulated with phorbol esters. This is most likely due to phorbol esters prolonging the stability of IL-3 and GM-CSF mRNA. 3 and 4) . The secretion of GM-CSF was also detected and confirmed by performing 3 H-thymidine incorporation assays in the presence and absence of antibodies specific to GM-CSF and IL-3 (data not presented).
Raf-responsive cells display density-dependent growth -a hallmark of autocrine transformation
To determine the effects of the autocrine GM-CSF expression, the cloning efficiency of the Raf-responsive cells was examined in the presence of GM-CSF and ␤-estradiol (Figure 7) . Even though the cells were Raf-responsive, GM-CSF increased
Figure 6
Autocrine GM-CSF expression in FD/⌬RaF:ER(Est) cells. The presence of IL-3 and GM-CSF transcripts was determined by RT-PCR. As a control for the levels of mRNAs examined, the presence of ␤ 2 -microglobulin RNAs was determined.
Figure 7
Effects of cell density on the cloning efficiency of Raf-responsive cells. FD/⌬A-Raf:ER(Est)c2 and FD/⌬Raf-1:ER(Est)c1 cells were plated at different cell concentrations in the presence of either 20% GM-CSF () or ␤-estradiol (̆). The cloning efficiency was estimated by the Poisson analysis from the 37% cultures negative for growth that is indicated by a dotted line. The solid arrow on the X-axis indicates the number of cells necessary to form a colony. the cloning efficiency 10-fold indicating that the cells displayed density-dependent growth. Similar results were obtained when IL-3 was used in place of GM-CSF (data not presented). Thus Raf is inducing an autocrine loop of transformation in these cells.
Conditionally activated Raf prevents apoptosis in FD/⌬Raf:ER cells
The effects of the activated ⌬Raf:ER genes on the induction of apoptosis in cytokine-dependent and Raf-responsive ⌬Raf:ER cells were examined. First we examined the effects of the Raf genes on a marker associated with early events in apoptosis, annexin V binding. Annexin V binds phosphatidylserine (PS) residues. PS residues are normally on the inner face of the cell membrane. When a cell starts to undergo apoptosis, the Leukemia localization of PS moves to the outer face of the cell membrane and is recognized by annexin V. The cells are also stained with propidium iodine which differentiates between living and dead cells. Thus this staining technique enables the investigator to determine the percentage of cells which are early apoptotic, later apoptotic (or necrotic cells), dead and alive cells (Figure 8) .
As can be observed in Figure 8 , culture of the cytokinedependent (a, g and m) and Raf-responsive (d, j and p) cells in the absence of exogenous IL-3 and ␤-estradiol resulted in 13 to 62% of the cells being stained with the annexin V-FITC (early phase of apoptosis, upper left quadrants). The cytokinedependent clones had a higher percentage of earlier apoptotic cells than their corresponding Raf-responsive clones. In addition, the percentage of cells which were late apoptotic/necrotic cells (upper right quadrants) were also higher in the cytokine-dependent than Raf-responsive cells.
Leukemia
Figure 8
Effects of RAF genes on early events in apoptosis. Cytokine-dependent and Raf-responsive FD/⌬A-Raf:ER, FD/⌬B-Raf:ER and FD/⌬Raf-1:ER were cultured for 24 h under the indicated conditions prior to staining with annexin V-FITC and propidium iodide (PI). Thus even though the cells were cultured in the absence of exogenous ␤-estradiol, less apoptosis was observed in the Raf-responsive cells, possibly due to the presence of an antiapoptotic activity.
In contrast, when the cells were cultured in IL-3 (b, e, h, k, n and q) a lower percentage of the cells were in the early apoptotic quadrant with the exception of FD/⌬Raf-1:ER(Est)c2 cells which preferred to be cultured in ␤-estradiol (these cells also showed a similar preference for ␤-estradiol in 3 H-thymidine incorporation assays as shown previously in Figure 2 ). When the cells were cultured in ␤-estradiol in the absence of IL-3, higher percentages of the cytokine-dependent cells were detected in the early and late apoptotic quadrants (c, i and o) than in the cytokine-independent cells (f, l and r). Interestingly, the cytokine-dependent FD/⌬A-Raf:ER(IL3)c2 (c) and FD/⌬B-Raf:ER(IL3)c2 cells showed significantly fewer cells in the early apoptotic quadrant when they were cultured with ␤-estradiol than when they were cultured in the absence of IL-3 (a and g).
To determine whether the expression of the ⌬Raf:ER proteins affected late apoptotic events in the cells, the effects of Raf on the formation of an apoptotic DNA fragment ladder were also examined. DNA fragmentation assays were performed on low molecular weight DNA isolated from cells grown in medium containing IL-3, ␤-estradiol or no growth supplement ( Figure 9 ). An apoptotic DNA fragment ladder was observed in uninfected FDC-P1 cells (group 1) when they were deprived of IL-3 for 24 h (a) or cultured in ␤-estradiol (c). IL-3 prevented the detection of an apoptotic DNA ladder in FDC-P1 cells (b). The absence of an apoptotic DNA ladder indicates that the cells have not undergone late apoptotic events. This DNA extraction procedure isolates predominately low molecular weight DNA, hence very little DNA is seen in the lanes in the absence of apoptosis. When the Raf-responsive FD/⌬Raf-1 [YY] :ER(Est)c1 cells (group 2) or FD/⌬A-Raf [YY] :ER(Est)c5 cells (group 3) were cultured in the absence of IL-3 (a) the cells underwent apoptosis. In contrast, the formation of an apoptotic DNA fragment ladder was not detected when the cells were cultured in either IL-3 (b) or ␤-estradiol (c) (ie the cells did not undergo apoptosis). Thus, the activation of the ⌬Raf:ER protein prevented apoptosis in the Raf-responsive cells in a conditional Raf-dependent fashion. Similar results were observed with the Raf-responsive FD/⌬B-Raf [DD] : ER(Est)c1 cells (data not presented).
Aberrant Raf expression induces malignant transformation
Parental FDC-P1 cells are non-tumorigenic upon injection into immunocompromised mice 1,6,10,58 therefore they serve as a good model system to analyze the effects of oncogenes on malignant transformation. To determine whether the increased or deregulated Raf expression rendered the FDC-P1 cells tumorigenic, Raf-1 and ⌬Raf-1 infected factor-independent cell lines, as well as control cell lines, were injected into immunocompromised mice ( Table 2 ). The factor-independent cell lines were derived after infection of FDC-P1 cells with the modified Raf genes lacking the ER domain in the pLNC retroviral vector. The parental IL-3 dependent line, FDC-P1 did not induce tumors in immunocompromised mice, even after prolonged periods of incubation time (Table 2) . Furthermore, tumors were also not observed in mice injected with pools or cells which remained IL3-dependent [FD/pLNL6(I+G)pool, FD/⌬Raf-1 (I+G) pool and FD/Raf-1 (I+G) pool]{(I+G) Pool = pool isolated in the presence of IL-3 and G418}.
Tumors were detected in mice injected with factor-independent FD/⌬Raf-1(DMEM) clones. These tumors were leukemias as they could be detected after palpation of the mice and could also be recovered from the bone marrow present in the femurs of the injected mice and propagated in vitro in the presence of G418 which would kill any cell which did not have the ⌬Raf-1 transgene. The latency period for tumor formation in the mice injected with these clones was longer than that observed with mice injected with v-Ha-Ras-transformed cells or cells transformed by an autocrine mechanism (FD/GM + -3 and FD/IL3 + -1). Interestingly, tumors were not observed in mice injected with the FD/Raf-1 factor-independent clones that contained the unaltered germline raf-1 cDNA. Both these as well as the factor-independent ⌬Raf-1-transformed cells were examined for expression and inheritance of the Raf proviruses. The cells contained and expressed the introduced Raf-1 proviruses (data not presented). Thus, the two different types of cytokine-independent cells varied in their ability to induce tumors upon injection into immunocompromised mice.
Leukemia Table 2 Tumorigenicity of Raf-infected FDC-P1 cells 
GM-CSF expression in the cytokine-independent FD/⌬Raf-1 cells
To examine possible mechanisms why the factor-independent FD/⌬Raf-1(DMEM) cells formed tumor whereas the factorindependent FD/Raf-1(DMEM) cells did not, the presence of autocrine cytokine expression was examined in the cytokineindependent FD/⌬Raf-1(DMEM) and FD/Raf-1(DMEM) cell lines that were injected into the mice (Figure 10 ). Interestingly autocrine GM-CSF expression was observed in the cytokineindependent FD/⌬Raf-1(DMEM) clones but not in the cytokine-independent FD/Raf-1(DMEM) cells. Thus the factorindependent FD/⌬Raf-1(DMEM) cells that expressed GM-CSF formed tumors whereas the FD/Raf-1(DMEM) cells which did not express detectable levels of autocrine cytokines did not form tumors.
Discussion
One of the goals of this research was to investigate the abilities of different activated Raf kinases to abrogate cytokine dependency and prevent apoptosis in hematopoietic cells. Using conditional forms of Raf kinases (⌬Raf:ER), we were able to isolate cells in which the requirement for IL-3 was replaced by the activation of ⌬Raf:ER by ␤-estradiol.
The conditionality of the ⌬Raf:ER proteins allowed us to demonstrate the requirement of the Raf kinase activity in the IL-3-independent growth as the cells failed to proliferate when ␤-estradiol was removed from the culture medium. This result, the observed frequency of conversion to IL-3 independence
Figure 10
Autocrine GM-CSF expression in FD/⌬Raf-1 cells. The presence of autocrine IL-3 and GM-CSF expression was examined by RT-PCR. DMEM = factor-independent clones isolated from FDC-P1 cells infected with the ⌬Raf-1 or ⌬Raf retroviruses. and the heterogeneity of retroviral integration sites (data not presented) eliminates the possibility of an insertional mutagenesis mechanism in the isolation of IL-3-independent cells.
Upon limiting dilution analysis of pools of FD/⌬Raf:ER cells (derived in puromycin and IL-3), we isolated cytokine-independent cells at a frequency of 1 in 2 × 10 3 to 5 × 10 5 infected cells. The vast majority of FDC-P1 cells infected with the ⌬Raf:ER encoding retroviruses were not converted to IL-3-independence. Experiments were also performed with FDC-P1 cells infected with a pLNC⌬Raf-1 virus, and a similar frequency of cytokine-independent cells was isolated as that observed with the pBP3⌬Raf-1 [YY] :ER virus. Together, these results indicate that the ER portion of the ⌬Raf:ER constructs did not inhibit the recovery of cytokine-independent cells.
Cytokine-independent FDC-P1 cells were more frequently recovered after either v-Src or v-Ha-Ras infection, indicating that while Ras lies immediately upstream of Raf in signal transduction pathways, there is a profound difference in the abilities of Ras and Raf to transform FDC-P1 cells to cytokine independence. This may be due to the ability of Ras to induce additional signal transduction pathways which are independent of Raf. Alternatively Ras may interact with both ARaf and Raf-1 and thus increase the recovery of cytokine independent cells as compared to the aberrant activation of either A-Raf or Raf-1 alone. Moreover, the v-Src oncoprotein was more efficient in abrogating the cytokine dependency than either the v-Ha-Ras or ⌬Raf oncoproteins suggesting that the v-Src oncoprotein can induce multiple signaling pathways which result in the abrogation of cytokine dependency. These additional signaling pathways appear to converge at MEK1 as the inhibitor PD98059 suppressed the 3 H-thymidine incorporation and growth of the v-Ha-Ras, ⌬Raf:ER, and v-Src, as well as autocrine-transformed FDC-P1 cells ( Figure 5 and data not presented). In contrast, the growth of BCR-ABL-transformed FDC-P1 cells was not as sensitive to the MEK1 inhibitor. It has been shown previously that BCR-ABL does not induce MAP (ERK2) kinase activity in hematopoietic cells. 59 Raf-responsive cell lines were recovered more efficiently when FDC-P1 cells were infected with a retrovirus encoding ⌬A-Raf:ER, while fewer Raf-responsive cells were recovered following infection with retroviruses encoding either ⌬Raf-1:ER or ⌬B-Raf:ER. These results indicated that there is a hierarchy in the capacities of the different Raf kinases to convert FDC-P1 cells to factor independence. This may be a consequence of differential activation of intracellular signaling pathways by the three Raf kinases.
It has recently been shown that these Raf kinases display qualitative and quantitative differences in their ability to phosphorylate and activate MEK1 in vitro and in vivo. 33, [35] [36] [37] [38] [39] Enhancement of the A-Raf kinase activity by mutating the critical tyrosine phosphorylation motifs (YY 340 and 341) to aspartic acid resulted in an increase in the recovery of Rafresponsive cells. This indicated that changing the phosphorylation residues could enhance the transforming activity of the A-Raf kinase. Moreover, mutation of these residues to phenylalanine resulted in a decrease in the recovery of cytokineindependent cells. In this regard, it was surprising that this mutated ⌬A-Raf [FF] :ER kinase retained some ability to abrogate the cytokine dependency of FDC-P1 cells since it did not transform NIH-3T3 cells. 35 These results suggest that there are other residues on the A-Raf protein which may be regulated after treatment with ␤-estradiol and confer activity to the ⌬A-Raf [FF] :ER protein. In contrast, changing either the DD or YY residues in B-Raf or Raf-1, respectively, to phenylalanine eliminated the abilities of these two Raf kinases to transform FDC-P1 cells. Chimeras between the A-Raf and either Raf-1 or B-Raf proteins could potentially determine which regions of the A-Raf kinase are responsible for abrogation of cytokine dependency.
Autocrine GM-CSF expression was detected in the Rafresponsive cells. The growth of the Raf-responsive cells was density-dependent as the cloning efficiency was enhanced by the addition of exogenous GM-CSF or IL-3. A lag in the proliferation of the Raf-responsive cells in response to ␤-estradiol was often observed (Figure 1 ). This may indicate that the cells have to synthesize sufficient GM-CSF for the cells to proliferate in response to Raf. Consistent with this hypothesis is the observation that the cells plated at high densities formed colonies faster than cells plated at low cell densities (data not shown).
Aberrant activation of the Raf/MEK/ERK proteins could result in the activation of p90 Rsk , CREB and Egr-1. [26] [27] [28] [29] [30] [31] [32] The CREB and Egr-1 transcription factors could stimulate GM-CSF transcription and result in autocrine transformation. Aberrant activation of the Raf/MEK/ERK pathway has been shown in other cell systems to induce autocrine growth factor expression. 15, 60 It is conceivable that overexpression of the ⌬Raf-1:ER and ⌬B-Raf:ER kinases are normally toxic to FDC-P1 cells, and it is only rare cells which can tolerate constitutively high levels of these kinases. Raf is known to induce the expression of the p21
Cip1 protein which normally serves to inhibit the actions of some of the cell cycle dependent kinases. 50, 55 A-Raf may be the best at abrogating the cytokine-dependency of FDC-P1 cells, since it is the weakest Raf kinase and a poor inducer of p21 Cip1 . 50 Alternatively, the ability of these Raf oncoproteins to abrogate cytokine-dependency of hematopoietic cells may be dependent upon their ability to prevent apoptosis. This anti-apoptotic function of the Raf proteins may be dependent upon other aspects of the Raf oncoproteins besides their intrinsic kinase activities.
A differential ability of the factor-independent cells isolated after infection with Raf-1 and ⌬Raf-1 retroviruses to form tumors in immunocompromised mice was observed. Even though both types of factor-independent cells grew in the absence of exogenous cytokines, the FD/⌬Raf-1 cell lines formed tumors, whereas the FD/Raf-1 lines did not. The MEK1 inhibitor suppressed the proliferation of both types of cells. We have also observed that in some other factor cell lines the level of IL-3 expression was correlated with the ability of the cells to form tumors in immunocompromised mice. 2, 58 The ability of the factor-independent FD/⌬Raf-1 cells to form tumors is likely due to the constitutive activation of the Raf kinase that stimulates autocrine GM-CSF expression. These results indicate that factor independence in vitro is not necessarily sufficient for tumorigenesis in vivo. Thus this tumor model separates cells that survive [FD/Raf-1(DMEM)] from those that proliferate [FD/⌬Raf-1(DMEM)]. These results indicate that survival signals are not always proliferative signals.
In conclusion, these experiments demonstrate that there are differences in the abilities of the three Raf oncoproteins to abrogate the cytokine dependency and prevent apoptosis in FDC-P1 cells. These variances may result from subtle distinctions in the three Raf kinases that fine-tune their biochemical activities. These events may alter their abilities to induce and interact with signal transduction and apoptotic pathways that regulate the cytokine dependency of hematopoietic cells. Further analysis of downstream substrates of the ERK1 and ERK2 molecules in these cells may elucidate the differences between cells that grow in response to Raf as opposed to those that remain IL-3 dependent. These ⌬Raf:ER infected cells will be useful in elaborating the contribution of the three Raf kinases in signal transduction, prevention of apoptosis and tumorigenicity of hematopoietic cells.
